Features September 2012 Issue

Study Finds Long-term Insulin Use Doesn’t Raise Heart Risks

Research also shows insulin use significantly lowers risks in individuals diagnosed with pre-diabetes.

For many years, physicians and researchers have debated the possible risks of long-term insulin use by patients with diabetes. Two recent studies, however, find that prolonged insulin use doesn’t harm people with diabetes or pre-diabetes, and doesn’t put them at greater risk of heart attacks, strokes or cancer. The research, published in the New England Journal of Medicine, also noted that people with pre-diabetes, who received daily basal insulin injections with the insulin glargine had a 28 percent lower chance of developing type 2 diabetes, even after the injections stopped. Glargine (Lantus) is a type of slow-release insulin that is injected once daily to help control blood glucose levels.

To continue reading this article you must be a paid subscriber.

Subscribe to Heart Advisor

Get the next year of HEART ADVISOR for just $20. That's a savings of $19 off the regular rate.

With your paid subscription you will receive unlimited access to all of our online content. That is over a decade of previous issues from Cleveland Clinic, the hospital rated #1 in cardiac care by U.S. News & World Report - free of charge.

Subscriber Log In

Forgot your password? Click Here.

Already subscribe but haven't registered for all the benefits of the website? Click here.